Biotech's Positive Results
Executive SummaryEveryone else may be talking about discovery-based biotechs, but the fact is, top-rated Goldman Sachs biotech analyst Maykin Ho told the February 6 Mayfield/Wilson Sonsini conference, "Financing the Biopharmaceutical Company," biotechs with clinical-stage products aren't doing badly.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.